Search Results 101-110 of 15023 for Hepatitis C

  1. Mayo Clinic Studies Identify Risk Factors in Rising Trend of Liver Cancer

    ... hepatitis C infection. "The liver scarring from hepatitis C can take 20 to 30 years to develop into cancer," Dr. Kim says. "We're now seeing cancer patients ...

  2. Mayo Clinic Radio: Fecal Microbiota Transplant / Living Donor Kidney Program / Hepatitis C

    Stacey Rizza outlines the risk of being infected with hepatitis C, especially for people born between 1945 and 1965. Listen to the program on Saturday, Aug ...

  3. Fecal Microbiota Transplant / Living Donor Kidney Program / Hepatitis C: Mayo Clinic Radio

    Stacey Rizza outlines the risk of being infected with hepatitis C, especially for people born between 1945 and 1965. Here's the Mayo Clinic Radio podcast ...

  4. A Study To Compare The Effectiveness And Safety Of ABT-493/ABT-530 To Sofosbuvir Given Together With Declatasvir In Adults With A Chronic Hepatitis C Virus Infection - Mayo Clinic

    A Study To Compare The Effectiveness And Safety Of ABT-493/ABT-530 To Sofosbuvir Given Together With Declatasvir In Adults With A Chronic Hepatitis C Virus ...

  5. Glecaprevir and pibrentasvir (oral route) - Mayo Clinic

    Glecaprevir and pibrentasvir combination is used to treat chronic hepatitis C virus (HCV) genotypes 1, 2, 3, 4, 5, or 6 infection in patients without cirrhosis ...

  6. Overview - Hepatobiliary Cancer Laboratory - Mayo Clinic Research

    The Hepatobiliary Cancer Lab of Lewis R. Roberts, M.B., Ch.B., Ph.D., at Mayo Clinic targets liver cancer genes and works to prevent hepatitis B and C ...

  7. Dr. Rohit Divekar Archives - Mayo Clinic News Network

    Left untreated, hepatitis C can cause serious liver damage, cirrhosis and even death. On the next Mayo Clinic Radio, infectious diseases specialist Dr. Stacey ...

  8. Sofosbuvir and velpatasvir (oral route) - Side effects & dosage - Mayo Clinic

    For hepatitis C virus infection: Adults—One tablet once a day, taken for 12 weeks. Each tablet contains sofosbuvir 400 milligrams (mg) and velpatasvir 100 ...

  9. A Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Co-Administration Of ABT-493 And ABT-530 With And Without RBV In Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 Or 6 Infection - Mayo Clinic

    ... Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 Or 6 Infection. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo ...

  10. The Making of an Expert - Mayo Clinic News Network

    Hepatitis C is spread by blood and becomes a long-term, chronic infection for 70% to 85% of infected people. Chronic hepatitis C can result in long-term ...